Colorectal screening program – participation of general gynecologists

Česká verzia

Authors: J. T. Kovářová
Authors place of work: IV. interní klinika VFN a 1. LF UK Praha, vedoucí pracoviště prof. A. Žák, DrSc.
Published in the journal: Ceska Gynekol 2011; 76(2): 157-161

Summary

Aim:
Colorectal screening program in the Czech republic in 2011 offers faecal occult blood test (FOBT) yearly in the age of 50-54. Patient over 55 years of age chooses either a FOBT once in 2 years or primary screening colonoscopy once in 10 years without using FOBT. There are different types of FOBT in our screening program: quaiac tests, immunochemical tests unquantitative and quantitative tests. The role of general practitioners was enhanced by participation of the gynecologists in the colorectal cancer screening program due to low compliance of population. Alternative ways of distribution of FOBT to the patients are being considered as well.

Conclusion:
Participation of general gynecologists in the Czech colorectal cancer screening program is connected with a great expectation. We would like to achieve such compliance in colorectal cancer screening as there is in the screening of gynecological tumors. Using a right method of screening could play an important role in this process.

Key words:
colorectal carcinoma, screening, general gynecologists, faecal occult blood test.

Zdroje

1. Courtier, R., Casamitjana, M., Macia, F., et al. Results of a study on populational colorectal cancer screening. Cir Esp, 2009, 85(3), p. 152-157.

2. Dubská, L., Nechvátal, J. Kvantitativní stanovení hemoglobinu ve stolici. Laboratorní technologie. Dostupný na http://www. stapro.cz/bullfons/32009/labo1.pdf.

3. Dušek, L., Abrahámová, J., Mužík, J., et al. Populační odhady počtu nemocných s kolorektálním karcinomem v ČR - jeden z nástrojů hodnocení včasné diagnostiky časných stadií a rekurence onemocnění. Farmakoterapie - speciální příloha Kolorektální karcinom, 2009, s. 11-20.

4. Frič, P., Zavoral, M., Dvořáková, H., et al. An adapted program of colorectal cancer screening – 7 years experience and cost-benefit analysis. Hepatogastroenterology, 1994, 41(5), p. 413‑416.

5. Grazzini, G., Visioli, CB., Zorzi, M., et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer, 2009, 100(2), p. 259-265.

6. Grazzini, G., Ventura, L., Kappa, MS., et al. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence distrikt. Gut, 2010, 59(11), p. 1511-1515.

7. Hol, L., Wilschut, JA., van Ballegooijen, M., et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer, 2009, 100(7), p. 1103-1110.

8. Hundt, S., Haug, U., Brenner, H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med, 2009, 150(3), p. 162-169.

9. Levi, Z., Rozen, P., Hazazi, R., et al. A Quantitative immunochemical fial occult blood test for colorectal neoplasia. Ann Intern Med, 2007, 146(4), p. 244-255.

10. Rossum, LG., Rijn, AF., Laheij, RJ., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology, 2008, 135(1), p. 82-90.

11. Rossum, LG., Rijn, AF., Oijen, MG., et al. False negative fecal occult blood test due to delayed sample return in colorectal cancer screening. Int J Cancer, 2009, 125(4), p. 746-750.

12. Rozen, P., Levi, Z., Hazazi, R., et al. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of test performed. Aliment Pharmacol Ther, 2009, 29(8), p. 906-917.

13. Vilkin, A., Rozen, P., Levi, Z., et al. Performance characteristic and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol, 2005, 100(11), p. 2519-2525.

14. Zavoral, M., Suchánek, S., Závada, F., et al. Colorectal cancer screening in Europe. World J Gastroenterol, 2009, 15(47), p. 5907-5915.